Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Instil Bio Inc. (TIL)

12.75   0.14 (1.11%) 01-19 09:31
Open: 13.37 Pre. Close: 12.61
High: 12.75 Low: 12.75
Volume: 5,785 Market Cap: 1,644M
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.022 - 14.121 14.121 - 14.198
Low: 12.43 - 12.526 12.526 - 12.601
Close: 12.486 - 12.633 12.633 - 12.747

Technical analysis

as of: 2022-01-19 9:24:40 AM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 19.89     One year: 23.08
Support: Support1: 12.60    Support2: 10.48
Resistance: Resistance1: 17.02    Resistance2: 19.76
Pivot: 15.10
Moving Average: MA(5): 13.31     MA(20): 15.32
MA(100): 18.93     MA(250):
MACD: MACD(12,26): -1.47     Signal(9): -1.26
Stochastic oscillator: %K(14,3): 4.06     %D(3): 5.04
RSI: RSI(14): 29.63
52-week: High: 29.49  Low: 12.60  Change(%): -52.3
Average Vol(K): 3-Month: 58042  10-Days: 31716

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TIL has closed above bottom band by 13.5%. Bollinger Bands are 22% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 11 Jan 2022
Why Tradeweb (TW) Could Be an Impressive Growth Stock - Nasdaq

Tue, 23 Nov 2021
Instil Bio (TIL) Shares Cross Below 200 DMA - Nasdaq

Wed, 10 Nov 2021
Was The Smart Money Right About Instil Bio, Inc. (TIL)? - Yahoo Finance

Mon, 08 Nov 2021
Instil Bio to Present at Upcoming Investor Conferences in November - GlobeNewswire

Mon, 13 Sep 2021
Instil Bio Receives IND Clearance to Initiate a Phase 2 Clinical Trial for Patients with Advanced Melanoma - GlobeNewswire

Thu, 02 Sep 2021
Instil Bio to Present at Upcoming Investor Conferences in September - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Financial Services
Industry:  Biotechnology
Shares Out. (M) 129
Shares Float (M) 66
% Held by Insiders 6.90
% Held by Institutions 56.30
Shares Short (K) 7,300
Shares Short P. Month (K) 5,310

Stock Financials

EPS -1.580
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.670
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.) 0.001
Sales Per Share
EBITDA (p.s.) -0.903
Qtrly Earnings Growth
Operating Cash Flow (M) -96
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -7.98
PEG Ratio
Price to Book value 2.70
Price to Sales
Price to Cash Flow -16.91

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.